| Name | Role stated in the filing | Named in |
|---|---|---|
| Vuong Trieu | The above is the Chief Executive Officer of Oncotelic and the Chief Executive Officer and President of EdgePoint AI, Inc., Executive Officer, Director | 2026-07-22, 2025-12-11, 2023-07-13 |
| Anthony Maida | The above is the Chief Medical Officer - Translation Officer of Oncotelic, Executive Officer, Director | 2026-07-22, 2023-07-13 |
| Saran Saund | The above is the Chief Business Officer of Oncotelic and Edgepoint AI, Executive Officer | 2026-07-22, 2023-07-13 |
| Seymour Fein | The above is the Chief Regulatory Officer of Oncotelic, Executive Officer | 2026-07-22, 2023-07-13 |
| Amit Shah | The above is the Chief Financial Officer of Oncotelic and of EdgePoint AI, Inc., Executive Officer | 2023-07-13 |
| Shah Amit | Executive Officer | 2026-07-22 |
| Steven King | Director | 2026-07-22 |
Want the whole picture on Oncotelic Therapeutics, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Oncotelic Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Oncotelic Therapeutics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Names and roles exactly as the filings list them: executive officers, directors and promoters. Nothing here is inferred, and a filing only lists the people it is required to.